210 related articles for article (PubMed ID: 11706932)
1. Refsum disease, peroxisomes and phytanic acid oxidation: a review.
Wanders RJ; Jansen GA; Skjeldal OH
J Neuropathol Exp Neurol; 2001 Nov; 60(11):1021-31. PubMed ID: 11706932
[TBL] [Abstract][Full Text] [Related]
2. Refsum disease: a defect in the alpha-oxidation of phytanic acid in peroxisomes.
Singh I; Pahan K; Singh AK; Barbosa E
J Lipid Res; 1993 Oct; 34(10):1755-64. PubMed ID: 7504046
[TBL] [Abstract][Full Text] [Related]
3. Phytanic acid: production from phytol, its breakdown and role in human disease.
van den Brink DM; Wanders RJ
Cell Mol Life Sci; 2006 Aug; 63(15):1752-65. PubMed ID: 16799769
[TBL] [Abstract][Full Text] [Related]
4. Phytanic acid oxidation: normal activation and transport yet defective alpha-hydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata.
Pahan K; Khan M; Singh I
J Lipid Res; 1996 May; 37(5):1137-43. PubMed ID: 8725164
[TBL] [Abstract][Full Text] [Related]
5. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
Wanders RJ; Komen JC
Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
[TBL] [Abstract][Full Text] [Related]
6. Phytanic acid metabolism in health and disease.
Wanders RJ; Komen J; Ferdinandusse S
Biochim Biophys Acta; 2011 Sep; 1811(9):498-507. PubMed ID: 21683154
[TBL] [Abstract][Full Text] [Related]
7. Phytanic acid alpha-oxidation, new insights into an old problem: a review.
Wanders RJ; Jansen GA; Lloyd MD
Biochim Biophys Acta; 2003 Mar; 1631(2):119-35. PubMed ID: 12633678
[TBL] [Abstract][Full Text] [Related]
8. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
[TBL] [Abstract][Full Text] [Related]
9. Role of phytanoyl-CoA 2-hydroxylase in phytanic acid metabolism.
Lloyd MD; Mukherji M; Kershaw NJ; Chien W; Wierzbicki AS; Schofield CJ
Adv Exp Med Biol; 2003; 544():303-4. PubMed ID: 14713244
[No Abstract] [Full Text] [Related]
10. Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation.
Wierzbicki AS; Lloyd MD; Schofield CJ; Feher MD; Gibberd FB
J Neurochem; 2002 Mar; 80(5):727-35. PubMed ID: 11948235
[TBL] [Abstract][Full Text] [Related]
11. Transport of phytanic acid on lipoproteins in Refsum disease.
Wierzbicki AS; Sankaralingam A; Lumb PJ; Hardman TC; Sidey MC; Gibberd FB
J Inherit Metab Dis; 1999 Feb; 22(1):29-36. PubMed ID: 10070615
[TBL] [Abstract][Full Text] [Related]
12. Atypical refsum disease with pipecolic acidemia and abnormal catalase distribution.
Baumgartner MR; Jansen GA; Verhoeven NM; Mooyer PA; Jakobs C; Roels F; Espeel M; Fourmaintraux A; Bellet H; Wanders RJ; Saudubray JM
Ann Neurol; 2000 Jan; 47(1):109-13. PubMed ID: 10632109
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial oxidation of phytanic acid in human and monkey liver: implication that Refsum's disease is not a peroxisomal disorder.
Watkins PA; Mihalik SJ
Biochem Biophys Res Commun; 1990 Mar; 167(2):580-6. PubMed ID: 1690986
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of phytanic acid alpha-oxidation intermediates in Zellweger fibroblasts.
Fingerhut R; Schmitz W; Conzelmann E
J Inherit Metab Dis; 1993; 16(3):591-4. PubMed ID: 7541878
[No Abstract] [Full Text] [Related]
15. Phytanic acid alpha-oxidation in rat liver peroxisomes. Production of alpha-hydroxyphytanoyl-CoA and formate is enhanced by dioxygenase cofactors.
Mihalik SJ; Rainville AM; Watkins PA
Eur J Biochem; 1995 Sep; 232(2):545-51. PubMed ID: 7556205
[TBL] [Abstract][Full Text] [Related]
16. Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review.
Wierzbicki AS
Biochem Soc Trans; 2007 Nov; 35(Pt 5):881-6. PubMed ID: 17956237
[TBL] [Abstract][Full Text] [Related]
17. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders.
Van Veldhoven PP; Huang S; Eyssen HJ; Mannaerts GP
J Inherit Metab Dis; 1993; 16(2):381-91. PubMed ID: 7692128
[TBL] [Abstract][Full Text] [Related]
18. Human metabolism of phytanic acid and pristanic acid.
Verhoeven NM; Jakobs C
Prog Lipid Res; 2001 Nov; 40(6):453-66. PubMed ID: 11591435
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of phytanic acid in Refsum's disease.
Billimoria JD; Clemens ME; Gibberd FB; Whitelaw MN
Lancet; 1982 Jan; 1(8265):194-6. PubMed ID: 6172683
[No Abstract] [Full Text] [Related]
20. Characterization of phytanic acid omega-hydroxylation in human liver microsomes.
Komen JC; Duran M; Wanders RJ
Mol Genet Metab; 2005 Jul; 85(3):190-5. PubMed ID: 15979030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]